David T Siefker1, Luan Vu1, Dahui You2,3, Andrew McBride2, Ryleigh Taylor2, Tamekia L Jones2,4,3, John DeVincenzo2,3, Stephania A Cormier1. 1. Department of Biological Sciences, College of Science, and Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana. 2. Department of Pediatrics, and. 3. Children's Foundation Research Institute, Le Bonheur Children's Hospital, Memphis, Tennessee. 4. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee; and.
Abstract
Rationale: Respiratory syncytial virus (RSV) causes significant morbidity and mortality in infants worldwide. Although T-helper type 2 (Th2) cell pathology is implicated in severe disease, the mechanisms underlying the development of immunopathology are incompletely understood. Objectives: We aimed to identify local immune responses associated with severe RSV in infants. Our hypothesis was that disease severity would correlate with enhanced Th2 cellular responses. Methods: Nasal aspirates were collected from infants hospitalized with severe (admitted to the pediatric ICU) or moderate (maintained in the general ward) RSV disease at 5 to 9 days after enrollment. The immune response was investigated by evaluating T-lymphocyte cellularity, cytokine concentration, and viral load.Measurements and Main Results: Patients with severe disease had increased proportions of CD8 (cluster of differentiation 8)-positive T cells expressing IL-4 (Tc2) and reduced proportions of CD8+ T cells expressing IFNγ (Tc1). Nasal aspirates from patients with severe disease had reduced concentrations of IL-17. Patients with greater frequencies of Tc1, CD8+ T cells expressing IL-17 (Tc17), and CD4+ T cells expressing IL-17 (Th17) had shorter durations of hospitalization.Conclusions: Severe RSV disease was associated with distinct T-cell profiles. Tc1, Tc17, and Th17 were associated with shorter hospital stay and may play a protective role, whereas Tc2 cells may play a previously underappreciated role in pathology.
Rationale: Respiratory syncytial virus (RSV) causes significant morbidity and mortality in infants worldwide. Although T-helper type 2 (Th2) cell pathology is implicated in severe disease, the mechanisms underlying the development of immunopathology are incompletely understood. Objectives: We aimed to identify local immune responses associated with severe RSV in infants. Our hypothesis was that disease severity would correlate with enhanced Th2 cellular responses. Methods: Nasal aspirates were collected from infants hospitalized with severe (admitted to the pediatric ICU) or moderate (maintained in the general ward) RSV disease at 5 to 9 days after enrollment. The immune response was investigated by evaluating T-lymphocyte cellularity, cytokine concentration, and viral load.Measurements and Main Results:Patients with severe disease had increased proportions of CD8 (cluster of differentiation 8)-positive T cells expressing IL-4 (Tc2) and reduced proportions of CD8+ T cells expressing IFNγ (Tc1). Nasal aspirates from patients with severe disease had reduced concentrations of IL-17. Patients with greater frequencies of Tc1, CD8+ T cells expressing IL-17 (Tc17), and CD4+ T cells expressing IL-17 (Th17) had shorter durations of hospitalization.Conclusions: Severe RSV disease was associated with distinct T-cell profiles. Tc1, Tc17, and Th17 were associated with shorter hospital stay and may play a protective role, whereas Tc2 cells may play a previously underappreciated role in pathology.
Authors: Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; Pingsheng Wu; William D Dupont; Edward F Mitchel; Rachel Enriquez; Tina V Hartert Journal: Pediatrics Date: 2008-07 Impact factor: 7.124
Authors: Carmen L Larrañaga; Sandra L Ampuero; Vivian F Luchsinger; Flavio A Carrión; Nelson V Aguilar; Pamela R Morales; María Angélica M Palomino; Lorena F Tapia; Luis F Avendaño Journal: Pediatr Infect Dis J Date: 2009-10 Impact factor: 2.129
Authors: H Kim Brand; Ronald de Groot; Joep M D Galama; Marianne L Brouwer; Karin Teuwen; Peter W M Hermans; Willem J G Melchers; Adilia Warris Journal: Pediatr Pulmonol Date: 2011-09-07
Authors: Hanne K Brand; Gerben Ferwerda; Frank Preijers; Ronald de Groot; Chris Neeleman; Frank J T Staal; Adilia Warris; Peter W M Hermans Journal: Pediatr Res Date: 2012-11-19 Impact factor: 3.756
Authors: Luan D Vu; Anh T Q Phan; Diego R Hijano; David T Siefker; Heather Tillman; Stephania A Cormier Journal: Am J Respir Cell Mol Biol Date: 2022-03 Impact factor: 6.914
Authors: Robinder G Khemani; Jessica T Lee; David Wu; Edward J Schenck; Margaret M Hayes; Patricia A Kritek; Gökhan M Mutlu; Hayley B Gershengorn; Rémi Coudroy Journal: Am J Respir Crit Care Med Date: 2021-05-01 Impact factor: 21.405
Authors: Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Katherine H Walker; Nandini Krishnamoorthy; Thayse R Brüggemann; Ashley E Shay; Charles N Serhan; Bruce D Levy Journal: Front Immunol Date: 2021-08-19 Impact factor: 7.561
Authors: Tatiana Chirkova; Christian Rosas-Salazar; Tebeb Gebretsadik; Samadhan J Jadhao; James D Chappell; R Stokes Peebles; William D Dupont; Dawn C Newcomb; Sergejs Berdnikovs; Peter J Gergen; Tina V Hartert; Larry J Anderson Journal: Front Immunol Date: 2022-03-17 Impact factor: 7.561